Trending
Berberine cut triglycerides by roughly 0.37 mmol/L in a meta-analysis of 4 trials — but only 2 of those studies saw a benefit, leaving the overall evidence low.
This pooled result is a signal worth watching, not a settled fact: a systematic review found berberine lowered triglycerides, fasting glucose, and waist circumference in metabolic syndrome, yet half the individual studies saw no effect, and the overall evidence grade is weak.
Researchers combined data from four small placebo-controlled trials of berberine in people with metabolic syndrome and found a statistically significant reduction in triglycerides (about 32 mg/dL on average), plus improvements in blood sugar and waist size. However, two of the four studies reported no triglyceride benefit, and the overall quality of the evidence is rated low, so the effect is not consistent or proven enough to rely on yet.
Where this fits in the evidence
Pillser has synthesized 4 studies on Berberine for Reduced Triglyceride Levels — overall evidence strength: Low.
Across 4 studies, 2 reported beneficial effects and 2 reported neutral effects, with a predominance of small effect sizes. The most common dose was 500 mg twice daily, and the median study duration was 84 days (12 weeks), suggesting effects are typically observed at this timeframe. Available evidence shows mixed results, with the strongest individual RCTs finding no significant difference between berberine and placebo for triglyceride reduction, while meta-analyses report small-to-moderate benefits.
The study
- Systematic Review
- 2025-07-16
- Frontiers in pharmacology
This is a plain-language summary of a research finding, not medical advice. Pillser surfaces research signals to help you decide what's worth investigating — always consult a qualified professional before changing what you take.